-
1
-
-
23744467281
-
Breast biopsy utilization a population-based study
-
DOI 10.1001/archinte.165.14.1593
-
Ghosh K, Melton LJ III, SumanVJ, Grant CS, Sterioff S, Brandt KR, et al. Breast biopsy utilization: a population-based study. Arch Intern Med 2005;165:1593-8. (Pubitemid 41124152)
-
(2005)
Archives of Internal Medicine
, vol.165
, Issue.14
, pp. 1593-1598
-
-
Ghosh, K.1
Joseph III, M.L.2
Suman, V.J.3
Grant, C.S.4
Sterioff, S.5
Brandt, K.R.6
Branch, C.7
Sellers, T.A.8
Hartmann, L.C.9
-
2
-
-
22344434177
-
Benign breast disease and the risk of breast cancer
-
DOI 10.1056/NEJMoa044383
-
Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, et al. Benign breast disease and the risk of breast cancer. N Engl J Med 2005;353:229-37. (Pubitemid 41058322)
-
(2005)
New England Journal of Medicine
, vol.353
, Issue.3
, pp. 229-237
-
-
Hartmann, L.C.1
Sellers, T.A.2
Frost, M.H.3
Lingle, W.L.4
Degnim, A.C.5
Ghosh, K.6
Vierkant, R.A.7
Maloney, S.D.8
Pankratz, V.S.9
Hillman, D.W.10
Suman, V.J.11
Johnson, J.12
Blake, C.13
Tlsty, T.14
Vachon, C.M.15
Melton III, L.J.16
Visscher, D.W.17
-
3
-
-
34447578893
-
Stratification of breast cancer risk in women with atypia: A mayo cohort study
-
DOI 10.1200/JCO.2006.09.0217
-
Degnim AC, Visscher DW, Berman HK, Frost MH, Sellers TA, Vierkant RA, et al. Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol 2007;25:2671-7. (Pubitemid 47123172)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.19
, pp. 2671-2677
-
-
Degnim, A.C.1
Visscher, D.W.2
Berman, H.K.3
Frost, M.H.4
Sellers, T.A.5
Vierkant, R.A.6
Maloney, S.D.7
Pankratz, V.S.8
De Groen, P.C.9
Lingle, W.L.10
Ghosh, K.11
Penheiter, L.12
Tlsty, T.13
Melton III, L.J.14
Reynolds, C.A.15
Hartmann, L.C.16
-
4
-
-
18744377172
-
High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer
-
Hoogerbrugge N, Bult P, de Widt-Levert LM, Beex LV, Kiemeney LA, Ligtenberg MJL, et al. High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer. J Clin Oncol 2003;21:41-5.
-
(2003)
J Clin Oncol
, vol.21
, pp. 41-45
-
-
Hoogerbrugge, N.1
Bult, P.2
De Widt-Levert, L.M.3
Beex, L.V.4
Kiemeney, L.A.5
Ligtenberg, M.J.L.6
-
5
-
-
0037378455
-
Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutations
-
DOI 10.1002/cncr.11225
-
Kauff ND, Brogi E, Scheuer L, Pathak DR, Borgen PI, Hudis CA, et al. Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutations. Cancer 2003;97:1601-8. (Pubitemid 36350702)
-
(2003)
Cancer
, vol.97
, Issue.7
, pp. 1601-1608
-
-
Kauff, N.D.1
Brogi, E.2
Scheuer, L.3
Pathak, D.R.4
Borgen, P.I.5
Hudis, C.A.6
Offit, K.7
Robson, M.E.8
-
6
-
-
0030337954
-
Identification of a chemoprevention cohort from a population of women at high risk for breast cancer
-
DOI 10.1002/(SICI)1097-4644(1996)25+<112::AID-JCB16>3.0.CO;2-Q
-
Fabian CJ, Kamel S, Zalles C, Kimler BF. Identification of a chemoprevention cohort from a population of women at high risk for breast cancer. J Cell Biochem Suppl 1996;25:112-22. (Pubitemid 27078320)
-
(1996)
Journal of Cellular Biochemistry
, vol.63
, Issue.SUPPL. 25
, pp. 112-122
-
-
Fabian, C.J.1
Kamel, S.2
Zalles, C.3
Kimler, B.F.4
-
7
-
-
0034990786
-
Histological and biological evolution of human premalignant breast disease
-
DOI 10.1677/erc.0.0080047
-
Allred DC, Mohsin SK, Fuqua SA. Histological and biological evolution of human premalignant breast disease. Endocr Relat Cancer 2001;8:47-61. (Pubitemid 32520253)
-
(2001)
Endocrine-Related Cancer
, vol.8
, Issue.1
, pp. 47-61
-
-
Allred, D.C.1
Mohsin, S.K.2
Fuqua, S.A.W.3
-
8
-
-
24944505221
-
Premalignant and in situ breast disease: Biology and clinical implications
-
Arpino G, Laucirica R, Elledge RM. Premalignant and in situ breast disease: biology and clinical implications. Ann Intern Med 2005;143:446-57. (Pubitemid 41338942)
-
(2005)
Annals of Internal Medicine
, vol.143
, Issue.6
, pp. 446-457
-
-
Arpino, G.1
Laucirica, R.2
Elledge, R.M.3
-
9
-
-
33646857926
-
Benign breast diseases: Classification, diagnosis, and management
-
DOI 10.1634/theoncologist.11-5-435
-
Guray M, Sahin AA. Benign breast diseases: classification, diagnosis, and management. Oncologist 2006;11:435-49. (Pubitemid 43788269)
-
(2006)
Oncologist
, vol.11
, Issue.5
, pp. 435-449
-
-
Guray, M.1
Sahin, A.A.2
-
10
-
-
77953022837
-
Ki67: A time-varying biomarker of risk of breast cancer in atypical hyperplasia
-
Santisteban M, Reynolds C, Barr Fritcher EG, Frost MH, Vierkant RA, Anderson SS, et al. Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasia. Breast Cancer Res Treat 2010;121:431-7.
-
(2010)
Breast Cancer Res Treat
, vol.121
, pp. 431-437
-
-
Santisteban, M.1
Reynolds, C.2
Barr Fritcher, E.G.3
Frost, M.H.4
Vierkant, R.A.5
Anderson, S.S.6
-
11
-
-
41449092563
-
Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancer
-
DOI 10.1093/jnci/djn036
-
Visscher DW, Pankratz VS, Santisteban M, Reynolds C, Ristimaki A, Vierkant RA, et al. Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancer. J Natl Cancer Inst 2008;100:421-7. (Pubitemid 351480513)
-
(2008)
Journal of the National Cancer Institute
, vol.100
, Issue.6
, pp. 421-427
-
-
Visscher, D.W.1
Pankratz, V.S.2
Santisteban, M.3
Reynolds, C.4
Ristimaki, A.5
Vierkant, R.A.6
Lingle, W.L.7
Frost, M.H.8
Hartmann, L.C.9
-
12
-
-
79955803865
-
Estrogen receptor expression in atypical hyperplasia: Lack of association with breast cancer
-
Barr Fritcher EG, Degnim AC, Hartmann LC, Radisky DC, Boughey J, Anderson S, et al. Estrogen receptor expression in atypical hyperplasia: lack of association with breast cancer. Cancer Prev Res 2011;4:435-44.
-
(2011)
Cancer Prev Res
, vol.4
, pp. 435-444
-
-
Barr Fritcher, E.G.1
Degnim, A.C.2
Hartmann, L.C.3
Radisky, D.C.4
Boughey, J.5
Anderson, S.6
-
13
-
-
35748943534
-
Abrogated Response to Cellular Stress Identifies DCIS Associated with Subsequent Tumor Events and Defines Basal-like Breast Tumors
-
DOI 10.1016/j.ccr.2007.10.017, PII S1535610807003029
-
Gauthier ML, Berman HK, Miller C, Kozakeiwicz K, Chew K, Moore D, et al. Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors. Cancer Cell 2007;12:479-91. (Pubitemid 350046408)
-
(2007)
Cancer Cell
, vol.12
, Issue.5
, pp. 479-491
-
-
Gauthier, M.L.1
Berman, H.K.2
Miller, C.3
Kozakeiwicz, K.4
Chew, K.5
Moore, D.6
Rabban, J.7
Chen, Y.Y.8
Kerlikowske, K.9
Tlsty, T.D.10
-
14
-
-
77952054026
-
Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis
-
Kerlikowske K, Molinaro AM, Gauthier ML, Berman HK, Waldman F, Bennington J, et al. Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J Natl Cancer Inst 2010;102:627-37.
-
(2010)
J Natl Cancer Inst
, vol.102
, pp. 627-637
-
-
Kerlikowske, K.1
Molinaro, A.M.2
Gauthier, M.L.3
Berman, H.K.4
Waldman, F.5
Bennington, J.6
-
15
-
-
41249098971
-
VHL Inactivation: A New Road to Senescence
-
DOI 10.1016/j.ccr.2008.03.012, PII S1535610808000950
-
Kim WY, Sharpless NE. VHL inactivation: a new road to senescence. Cancer Cell 2008;13:295-7. (Pubitemid 351446201)
-
(2008)
Cancer Cell
, vol.13
, Issue.4
, pp. 295-297
-
-
Kim, W.Y.1
Sharpless, N.E.2
-
16
-
-
84900969225
-
Ink4a/Arf expression is a biomarker of aging
-
DOI 10.1172/JCI200422475
-
Krishnamurthy J, Torrice C, Ramsey MR, Kovalev GI, Al-Regaiey K, Su L, et al. Ink4a/Arf expression is a biomarker of aging. J Clin Invest 2004;114:1299-307. (Pubitemid 40385301)
-
(2004)
Journal of Clinical Investigation
, vol.114
, Issue.9
, pp. 1299-1307
-
-
Krishnamurthy, J.1
Torrice, C.2
Ramsey, M.R.3
Kovalev, G.I.4
Al-Regaiey, K.5
Su, L.6
Sharpless, N.E.7
-
17
-
-
59449086167
-
The functional loss of the retinoblastoma tumour suppressor is a common event in basallike and luminal B breast carcinomas
-
Herschkowitz JI, He X, Fan C, Perou CM. The functional loss of the retinoblastoma tumour suppressor is a common event in basallike and luminal B breast carcinomas. Breast Cancer Res 2008;10:R75.
-
(2008)
Breast Cancer Res
, vol.10
-
-
Herschkowitz, J.I.1
He, X.2
Fan, C.3
Perou, C.M.4
-
18
-
-
77955837344
-
Breast cancer precursors revisited: Molecular features and progression pathways
-
Lopez-Garcia MA, Geyer FC, Lacroix-Triki M, Marchio C, Reis-Filho JS. Breast cancer precursors revisited: molecular features and progression pathways. Histopathology 2010;57:171-92.
-
(2010)
Histopathology
, vol.57
, pp. 171-192
-
-
Lopez-Garcia, M.A.1
Geyer, F.C.2
Lacroix-Triki, M.3
Marchio, C.4
Reis-Filho, J.S.5
-
20
-
-
0033616908
-
Estimation of failure probabilities in the presence of competing risks: New representations of old estimators
-
DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O
-
Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999;18:695-706. (Pubitemid 29126745)
-
(1999)
Statistics in Medicine
, vol.18
, Issue.6
, pp. 695-706
-
-
Gooley, T.A.1
Leisenring, W.2
Crowley, J.3
Storer, B.E.4
-
21
-
-
13944270339
-
Senescent cells, tumor suppression, and organismal aging: Good citizens, bad neighbors
-
DOI 10.1016/j.cell.2005.02.003
-
Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005;120:513-22. (Pubitemid 40269765)
-
(2005)
Cell
, vol.120
, Issue.4
, pp. 513-522
-
-
Campisi, J.1
-
22
-
-
77955916897
-
Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia
-
Boughey JC, Hartmann LC, Anderson SS, Degnim AC, Vierkant RA, Reynolds CA, et al. Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia. J Clin Oncol 2010;28:3591-6.
-
(2010)
J Clin Oncol
, vol.28
, pp. 3591-3596
-
-
Boughey, J.C.1
Hartmann, L.C.2
Anderson, S.S.3
Degnim, A.C.4
Vierkant, R.A.5
Reynolds, C.A.6
-
23
-
-
56749104462
-
Assessment of the accuracy of the Gail model in women with atypical hyperplasia
-
Pankratz VS, Hartmann LC, Degnim AC, Vierkant RA, Ghosh K, Vachon CM, et al. Assessment of the accuracy of the Gail model in women with atypical hyperplasia. J Clin Oncol 2008;26:5374-9.
-
(2008)
J Clin Oncol
, vol.26
, pp. 5374-5379
-
-
Pankratz, V.S.1
Hartmann, L.C.2
Degnim, A.C.3
Vierkant, R.A.4
Ghosh, K.5
Vachon, C.M.6
-
24
-
-
33751364628
-
Age-related lobular involution and risk of breast cancer
-
DOI 10.1093/jnci/djj439
-
Milanese TR, Hartmann LC, Sellers TA, Frost MH, Vierkant RA, Maloney SD, et al. Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst 2006;98:1600-7. (Pubitemid 44811643)
-
(2006)
Journal of the National Cancer Institute
, vol.98
, Issue.22
, pp. 1600-1607
-
-
Milanese, T.R.1
Hartmann, L.C.2
Sellers, T.A.3
Frost, M.H.4
Vierkant, R.A.5
Maloney, S.D.6
Pankratz, V.S.7
Degnim, A.C.8
Vachon, C.M.9
Reynolds, C.A.10
Thompson, R.A.11
Melton III, L.J.12
Goode, E.L.13
Visscher, D.W.14
-
25
-
-
33749172559
-
Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a
-
Janzen V, Forkert R, Fleming HE, Saito Y, Waring MT, Dombkowski DM, et al. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 2006;443:421-6.
-
(2006)
Nature
, vol.443
, pp. 421-426
-
-
Janzen, V.1
Forkert, R.2
Fleming, H.E.3
Saito, Y.4
Waring, M.T.5
Dombkowski, D.M.6
-
26
-
-
33749187810
-
p16INK4a induces an age-dependent decline in islet regenerative potential
-
Krishnamurthy J, Ramsey MR, Ligon KL, Torrice C, Koh A, Bonner-Weir S, et al. p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 2006;443:453-7.
-
(2006)
Nature
, vol.443
, pp. 453-457
-
-
Krishnamurthy, J.1
Ramsey, M.R.2
Ligon, K.L.3
Torrice, C.4
Koh, A.5
Bonner-Weir, S.6
-
27
-
-
33748327046
-
INK4A is a robust in vivo biomarker of cellular aging in human skin
-
DOI 10.1111/j.1474-9726.2006.00231.x
-
Ressler S, Bartkova J, Niederegger H, Bartek J, Scharffetter-Kochanek K, Jansen-Durr P, et al. p16INK4A is a robust in vivo biomarker of cellular aging in human skin. Aging Cell 2006;5:379-89. (Pubitemid 44322534)
-
(2006)
Aging Cell
, vol.5
, Issue.5
, pp. 379-389
-
-
Ressler, S.1
Bartkova, J.2
Niederegger, H.3
Bartek, J.4
Scharffetter-Kochanek, K.5
Jansen-Durr, P.6
Wlaschek, M.7
-
28
-
-
79951912532
-
Four faces of cellular senescence
-
Rodier F, Campisi J. Four faces of cellular senescence. J Cell Biol 2011;192:547-56.
-
(2011)
J Cell Biol
, vol.192
, pp. 547-556
-
-
Rodier, F.1
Campisi, J.2
-
29
-
-
46449083569
-
Arf in senescence and ageing caused by BubR1 insufficiency
-
DOI 10.1038/ncb1744, PII NCB1744
-
Baker DJ, Perez-Terzic C, Jin F, Pitel K, Niederlander NJ, Jeganathan K, et al. Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency. Nat Cell Biol 2008;10:825-36. (Pubitemid 351927711)
-
(2008)
Nature Cell Biology
, vol.10
, Issue.7
, pp. 825-836
-
-
Baker, D.J.1
Perez-Terzic, C.2
Jin, F.3
Pitel, K.4
Niederlander, N.J.5
Jeganathan, K.6
Yamada, S.7
Reyes, S.8
Rowe, L.9
Hiddinga, H.J.10
Eberhardt, N.L.11
Terzic, A.12
Van Deursen, J.M.13
-
30
-
-
77949881221
-
The senescenceassociated secretory phenotype: The dark side of tumor suppression
-
Coppe JP, Desprez PY, Krtolica A, Campisi J. The senescenceassociated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 2010;5:99-118.
-
(2010)
Annu Rev Pathol
, vol.5
, pp. 99-118
-
-
Coppe, J.P.1
Desprez, P.Y.2
Krtolica, A.3
Campisi, J.4
-
31
-
-
84891713034
-
Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor
-
Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP, Goldstein J, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 2008;6:2853-68.
-
(2008)
PLoS Biol
, vol.6
, pp. 2853-2868
-
-
Coppe, J.P.1
Patil, C.K.2
Rodier, F.3
Sun, Y.4
Munoz, D.P.5
Goldstein, J.6
|